4//SEC Filing
NEOGENOMICS INC 4
Accession 0001209191-17-022294
$NEOCIK 0001077183operating
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 4:15 PM ET
Size
12.2 KB
Accession
0001209191-17-022294
Insider Transaction Report
Form 4
BRODIE STEVEN G.
Chief Scientific Officer
Transactions
- Sale
Common Stock
2017-03-20$7.90/sh−33,450$264,255→ 15,953 total - Sale
Common Stock
2017-03-13$8.00/sh−16,550$132,400→ 49,403 total
Holdings
- 20,000
Stock Option (Right to Buy)
Exercise: $3.45From: 2015-03-05Exp: 2019-03-05→ Common Stock (20,000 underlying) - 120,000
Stock Option (Right to Buy)
Exercise: $4.78From: 2016-05-04Exp: 2020-05-04→ Common Stock (120,000 underlying) - 100,000
Stock Option (Right to Buy)
Exercise: $7.15From: 2017-04-20Exp: 2021-04-20→ Common Stock (100,000 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $3.76From: 2014-04-16Exp: 2018-04-16→ Common Stock (10,000 underlying)
Footnotes (5)
- [F1]This line is included for purposes of amending the filing on 3/17/2017 which inadvertently showed the transaction as securities acquired rather than securities disposed of.
- [F2]On April 16, 2013 Dr. Brodie was granted 10,000 stock options. These options will vest ratably over the next three anniversary dates of the grant dates.
- [F3]On March 5, 2014 Dr. Brodie was granted 20,000 stock options. The options will vest ratably over the next three anniversary dates of the grant date.
- [F4]On May 4, 2015 Dr, Brodie was granted 120,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.
- [F5]On April 20, 2016, Mr. Brodie was granted 100,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001077183
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 4:15 PM ET
- Size
- 12.2 KB